Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Absorption kinetics of cyclosporin in the rat

View through CrossRef
Abstract Cyclosporin was administered (6 mg kg−1, i.v.) over 15 min, or (10 mg kg−1) by gavage, to two groups of 5 rats. Following i.v. infusion, cyclosporin exhibited triphasic behaviour with mean ± s.e.m. disposition half-lives of 9·0 ± 1·3 min, 4·0 ± 0·5 h and 16·0 ± 1·7 h. Following oral administration, peak blood concentration (Cmax) of 1290 ± 93 ng mL−1 was reached after 5 h, when cyclosporin absorption essentially ceased. The absolute bioavailability (F) of cyclosporin was 24·0%. Standard laboratory rat chow consisting of 2% corn oil did not appear to alter cyclosporin absorption kinetics.
Title: Absorption kinetics of cyclosporin in the rat
Description:
Abstract Cyclosporin was administered (6 mg kg−1, i.
v.
) over 15 min, or (10 mg kg−1) by gavage, to two groups of 5 rats.
Following i.
v.
infusion, cyclosporin exhibited triphasic behaviour with mean ± s.
e.
m.
disposition half-lives of 9·0 ± 1·3 min, 4·0 ± 0·5 h and 16·0 ± 1·7 h.
Following oral administration, peak blood concentration (Cmax) of 1290 ± 93 ng mL−1 was reached after 5 h, when cyclosporin absorption essentially ceased.
The absolute bioavailability (F) of cyclosporin was 24·0%.
Standard laboratory rat chow consisting of 2% corn oil did not appear to alter cyclosporin absorption kinetics.

Related Results

Can clinical response to cyclosporin in chronic severe asthma be predicted by an in vitro T-lymphocyte proliferation assay?
Can clinical response to cyclosporin in chronic severe asthma be predicted by an in vitro T-lymphocyte proliferation assay?
This study tests the hypothesis that the clinical response to cyclosporin therapy of patients with chronic severe asthma is related to the sensitivity of their T-lymphocytes to the...
Diltiazem‐cyclosporin pharmacokinetic interaction — dose–response relationship
Diltiazem‐cyclosporin pharmacokinetic interaction — dose–response relationship
Aims To study the dose‐response relationship of the pharmacokinetic interaction between diltiazem and cyclosporin in kidney transplant recipients. Methods Eight stable kidney trans...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...
CYCLOSPORIN A IN THE TREATMENT OF CHILDHOOD GLOMERULONEPHRITIS
CYCLOSPORIN A IN THE TREATMENT OF CHILDHOOD GLOMERULONEPHRITIS
AbstractSeven children with steroid resistant nephrotic syndrome (focal segmental sclerosis in six, mesangial proliferation in one) were treated with Cyclosporin A for 12 weeks. Fi...

Back to Top